Recreo Pharmaceuticals
Superior, US · Founded 2013 · Delaware LLC
Founders & leadership
XW
Xiang WangExecutive
XD
Xiaochang DuanExecutive
Board
TW
Tila WeiBoard director
Reported raises · per SEC filings
Form D private placements$3.2M disclosed across 2 rounds · 2016–2017
▶$3MraisedNov 2017 · 3 investors · OtherRule 506(b)
▶$3MraisedNov 2017 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- QUING WU WEIDirector
- Xiang WangExecutive Officer, Director
- XIAOCHANG DUANExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Nov 2017
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$250KraisedMar 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$250KraisedMar 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Tila WeiDirector
- Xiang WangExecutive Officer, Director
- Xiaochang DuanExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $250K
- First sale
- Feb 2016
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Recreo Pharmaceuticals raised?
- Recreo Pharmaceuticals has disclosed $3.2M raised across 2 rounds.
- Where is Recreo Pharmaceuticals headquartered?
- Recreo Pharmaceuticals is headquartered in Superior, US.